Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP894859.RAcSE36XMsKQ7BP7Qn2U4H_1aV4BDMmqJg-NCi5KYCDUc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP894859.RAcSE36XMsKQ7BP7Qn2U4H_1aV4BDMmqJg-NCi5KYCDUc130_assertion type Assertion NP894859.RAcSE36XMsKQ7BP7Qn2U4H_1aV4BDMmqJg-NCi5KYCDUc130_head.
- NP894859.RAcSE36XMsKQ7BP7Qn2U4H_1aV4BDMmqJg-NCi5KYCDUc130_assertion wasGeneratedBy ECO_0000203 NP894859.RAcSE36XMsKQ7BP7Qn2U4H_1aV4BDMmqJg-NCi5KYCDUc130_provenance.
- NP894859.RAcSE36XMsKQ7BP7Qn2U4H_1aV4BDMmqJg-NCi5KYCDUc130_assertion wasDerivedFrom befree-20140225 NP894859.RAcSE36XMsKQ7BP7Qn2U4H_1aV4BDMmqJg-NCi5KYCDUc130_provenance.
- NP894859.RAcSE36XMsKQ7BP7Qn2U4H_1aV4BDMmqJg-NCi5KYCDUc130_assertion SIO_000772 23924660 NP894859.RAcSE36XMsKQ7BP7Qn2U4H_1aV4BDMmqJg-NCi5KYCDUc130_provenance.
- NP894859.RAcSE36XMsKQ7BP7Qn2U4H_1aV4BDMmqJg-NCi5KYCDUc130_assertion evidence source_evidence_literature NP894859.RAcSE36XMsKQ7BP7Qn2U4H_1aV4BDMmqJg-NCi5KYCDUc130_provenance.
- NP894859.RAcSE36XMsKQ7BP7Qn2U4H_1aV4BDMmqJg-NCi5KYCDUc130_assertion description "[Treatment of hepatitis C virus (HCV) infection with boceprevir, peginterferon, and ribavirin can lead to anemia, which has been managed by reducing ribavirin dose and/or erythropoietin therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP894859.RAcSE36XMsKQ7BP7Qn2U4H_1aV4BDMmqJg-NCi5KYCDUc130_provenance.